IRadimed Corporation (IRMD) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

IRadimed Corporation (IRMD) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

IRMD Income Statement

IRadimed Corporation (IRMD) annual income statement — 14-year revenue, gross profit & net income history

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Sales/Revenue	20.47M	21.98M	22.69M	21.2M	20.41M	19.51M	19.39M	18.33M	17.93M	17.6M	17.45M	16.5M	16.13M	15.48M	14.86M	13.41M	12.72M	12.31M	11.87M	10.91M
Revenue Growth %	0.28%	12.65%	17.03%	15.69%	13.84%	10.87%	11.1%	11.04%	11.15%	13.72%	17.42%	23.1%	26.8%	25.7%	25.19%	22.92%	29.67%	33.46%	38.93%	41.67%
Cost of Goods Sold	5.31M	5.17M	5.66M	4.71M	4.45M	4.67M	4.63M	4.13M	3.92M	4.21M	4.04M	3.67M	3.94M	3.75M	3.64M	2.86M	2.58M	2.93M	2.62M	2.5M
COGS % of Revenue	25.93%	23.5%	24.94%	22.2%	21.83%	23.92%	23.87%	22.56%	21.86%	23.93%	23.14%	22.22%	24.45%	24.26%	24.51%	21.37%	20.29%	23.81%	22.09%	22.94%
Gross Profit	15.16M	16.81M	17.03M	16.49M	15.95M	14.84M	14.76M	14.19M	14.01M	13.39M	13.41M	12.84M	12.19M	11.72M	11.22M	10.54M	10.14M	9.38M	9.25M	8.41M
Gross Margin %	74.07%	76.5%	75.06%	77.8%	78.17%	76.08%	76.13%	77.44%	78.14%	76.07%	76.86%	77.78%	75.55%	75.74%	75.49%	78.63%	79.71%	76.19%	77.91%	77.06%
Gross Profit Growth %	-4.98%	13.28%	15.39%	16.23%	13.89%	10.87%	10.05%	10.55%	14.96%	14.22%	19.54%	21.77%	20.19%	24.97%	21.3%	25.43%	38.29%	32.81%	43.64%	46.41%
Operating Expenses	8.77M	9.58M	9.94M	9.66M	9.17M	9.41M	8.96M	8.4M	8.38M	8.64M	8.25M	6.93M	7.22M	7.71M	6.97M	6.41M	5.97M	6.3M	6.14M	5.32M
OpEx % of Revenue	42.85%	43.57%	43.8%	45.56%	44.92%	48.24%	46.21%	45.85%	46.75%	49.09%	47.29%	42%	44.78%	49.85%	46.87%	47.81%	46.95%	51.21%	51.72%	48.76%
Selling, General & Admin	8.11M	8.62M	9.14M	8.99M	8.29M	8.79M	8.39M	7.76M	7.58M	7.82M	7.6M	6.48M	6.26M	6.92M	6.36M	5.92M	5.31M	5.79M	5.65M	4.84M
SG&A % of Revenue	39.64%	39.22%	40.27%	42.38%	40.62%	45.04%	43.27%	42.36%	42.29%	44.43%	43.56%	39.26%	38.82%	44.72%	42.8%	44.15%	41.74%	47%	47.55%	44.36%
Research & Development	657K	956K	799K	674.36K	877.36K	624.25K	569.99K	639.47K	801.13K	821K	650.43K	452.56K	961.95K	793.72K	604.74K	491.64K	662.6K	519.1K	494.85K	480.7K
R&D % of Revenue	3.21%	4.35%	3.52%	3.18%	4.3%	3.2%	2.94%	3.49%	4.47%	4.67%	3.73%	2.74%	5.96%	5.13%	4.07%	3.67%	5.21%	4.22%	4.17%	4.41%
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0
Operating Income	6.39M	7.24M	7.09M	6.83M	6.79M	5.43M	5.8M	5.79M	5.63M	4.75M	5.16M	5.91M	4.96M	4.01M	4.25M	4.13M	4.17M	3.07M	3.11M	3.09M
Operating Margin %	31.23%	32.93%	31.26%	32.23%	33.26%	27.84%	29.91%	31.59%	31.39%	26.98%	29.57%	35.78%	30.77%	25.89%	28.62%	30.82%	32.75%	24.98%	26.19%	28.3%
Operating Income Growth %	-5.85%	33.24%	22.31%	18.04%	20.63%	14.39%	12.41%	-1.97%	13.38%	18.49%	21.3%	42.91%	19.12%	30.32%	36.8%	33.87%	125.93%	73.04%	377.64%	293.35%
EBITDA	6.8M	7.69M	7.71M	7.22M	7.38M	5.63M	6M	5.99M	5.83M	4.97M	5.37M	6.1M	5.15M	4.19M	3.56M	4.57M	4.66M	3.51M	3.5M	3.43M
EBITDA Margin %	33.23%	35%	33.97%	34.04%	36.16%	28.83%	30.92%	32.67%	32.5%	28.27%	30.74%	36.93%	31.93%	27.07%	23.96%	34.07%	36.64%	28.5%	29.45%	31.42%
EBITDA Growth %	-7.86%	36.73%	28.57%	20.56%	26.68%	13.09%	11.74%	-1.78%	13.12%	18.73%	50.67%	33.44%	10.51%	19.41%	1.85%	33.29%	112.58%	66.39%	253.13%	207.15%
D&A (Non-Cash Add-back)	409K	455K	614K	383.72K	592.45K	194.12K	194.87K	197.57K	199.13K	226.09K	205.38K	189.9K	187.36K	182.55K	-692.9K	435.48K	494.18K	433.93K	386.6K	340.13K
EBIT	6.39M	7.77M	7.79M	7.3M	7.33M	5.95M	6.34M	6.42M	6.27M	5.24M	5.16M	5.91M	4.96M	4.01M	4.25M	4.13M	4.17M	3.07M	3.11M	3.09M
Net Interest Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Income/Expense	497K	532K	697K	463.98K	539.25K	513.97K	544.16K	629.2K	642.22K	495.15K	521.81K	503.19K	335.39K	342.41K	449.73K	105.18K	13.1K	-14.91K	3.93K	7.14K
Pretax Income	6.89M	7.77M	7.79M	7.3M	7.33M	5.95M	6.34M	6.42M	6.27M	5.24M	5.68M	6.41M	5.3M	4.35M	4.7M	4.24M	4.18M	3.06M	3.11M	3.09M
Pretax Margin %	33.66%	35.35%	34.33%	34.42%	35.9%	30.47%	32.72%	35.02%	34.97%	29.8%	32.56%	38.83%	32.85%	28.11%	31.64%	31.61%	32.86%	24.86%	26.22%	28.37%
Income Tax	1.67M	1.95M	1.35M	1.72M	1.55M	1.26M	1.2M	1.37M	1.37M	1.11M	1.14M	1.34M	1.12M	943.59K	1.03M	810.38K	938.63K	573.29K	-779.17K	517.77K
Effective Tax Rate %	24.25%	25.11%	17.31%	23.58%	21.2%	21.16%	18.88%	21.33%	21.82%	21.11%	20.1%	20.93%	21.11%	21.69%	21.9%	19.12%	22.46%	18.74%	-25.03%	16.73%
Net Income	5.22M	5.82M	6.44M	5.58M	5.77M	4.69M	5.15M	5.05M	4.9M	4.14M	4.54M	5.07M	4.18M	3.41M	3.67M	3.43M	3.24M	2.49M	3.89M	2.58M
Net Margin %	25.5%	26.47%	28.39%	26.3%	28.29%	24.02%	26.54%	27.55%	27.34%	23.51%	26.01%	30.7%	25.91%	22.01%	24.72%	25.56%	25.48%	20.2%	32.79%	23.62%
Net Income Growth %	-9.63%	24.12%	25.17%	10.44%	17.81%	13.32%	13.37%	-0.35%	17.26%	21.45%	23.58%	47.86%	28.97%	36.97%	-5.63%	33.03%	120.53%	79.31%	510.7%	139.73%
Net Income (Continuing)	5.22M	5.82M	6.44M	5.58M	5.77M	4.69M	5.15M	5.05M	4.9M	4.14M	4.54M	5.07M	4.18M	3.41M	3.67M	3.43M	3.24M	2.49M	3.89M	2.58M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	0.41	0.45	0.50	0.43	0.45	0.37	0.40	0.40	0.38	0.32	0.36	0.40	0.33	0.27	0.29	0.27	0.26	0.20	0.31	0.20
EPS Growth %	-8.89%	21.62%	25%	7.5%	18.42%	15.63%	11.11%	0%	15.15%	18.52%	24.14%	48.15%	26.92%	35%	-6.45%	35%	116.67%	81.82%	520%	122.22%
EPS (Basic)	0.41	0.46	0.51	0.44	0.45	0.37	0.41	0.40	0.39	0.33	0.36	0.40	0.33	0.27	0.29	0.27	0.26	0.20	0.31	0.21
Diluted Shares Outstanding	12.87M	12.87M	12.88M	12.86M	12.83M	12.83M	12.78M	12.78M	12.76M	12.75M	12.74M	12.74M	12.72M	12.69M	12.63M	12.63M	12.63M	12.66M	12.63M	12.6M
Basic Shares Outstanding	12.78M	12.78M	12.74M	12.72M	12.72M	12.71M	12.68M	12.67M	12.66M	12.66M	12.62M	12.6M	12.6M	12.59M	12.57M	12.56M	12.56M	12.55M	12.43M	12.33M
Dividend Payout Ratio	49%	43.93%	132.79%	38.78%	37.44%	46.11%	36.94%	37.64%	38.76%	192.82%	-	-	-	388.22%	-	-	-	505.05%	-	-